ý

Feature Channels: Biotech

Filters close
Go to Advanced Search
Newswise: Van Andel Institute’s Dr. Hui Shen elected to the AIMBE College of Fellows
Released: 31-Mar-2025 7:40 PM EDT
Van Andel Institute’s Dr. Hui Shen elected to the AIMBE College of Fellows
Van Andel Institute

Van Andel Institute’s Hui Shen, Ph.D., has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, a prestigious appointment that represents the top 2% of medical and biological engineers.

Newswise: Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics
Released: 31-Mar-2025 3:00 PM EDT
Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics
Mount Sinai Health System

Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

Newswise: Experimental Blood Test Shown to Accurately Indicate Severity and Predict Potential Recovery from Spinal Cord Injury
Released: 31-Mar-2025 11:00 AM EDT
Experimental Blood Test Shown to Accurately Indicate Severity and Predict Potential Recovery from Spinal Cord Injury
Johns Hopkins Medicine

By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.

Newswise: New Method Creates 854x More Mitochondria, Offering Hope for Cartilage Regeneration
Released: 31-Mar-2025 6:10 AM EDT
New Method Creates 854x More Mitochondria, Offering Hope for Cartilage Regeneration
Chinese Academy of Sciences

Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming treatments for degenerative diseases. By refining stem cell culture conditions, researchers achieved an extraordinary 854-fold increase in mitochondrial production while significantly enhancing energy output.

Released: 28-Mar-2025 7:00 PM EDT
Meniscus Injuries May Soon Be Treated by Customizable Hydrogel
Perelman School of Medicine at the University of Pennsylvania

A new 3D printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears

Newswise: Brain Channels ‘Stopped in Time’ Reveal Chemical Flow That Enables Learning and Thinking
Released: 28-Mar-2025 6:45 PM EDT
Brain Channels ‘Stopped in Time’ Reveal Chemical Flow That Enables Learning and Thinking
Johns Hopkins Medicine

A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.

Released: 28-Mar-2025 5:50 PM EDT
MiRus Siegel™ TAVR: First EFS Cases
MiRus

MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic transcatheter heart valve (THV).

   
Newswise: FAMU-FSU College of Engineering Researchers Create Innovative Microparticles That Unlock New Insights Into Protein Degradation and Immune Cell Behavior
Released: 27-Mar-2025 7:50 PM EDT
FAMU-FSU College of Engineering Researchers Create Innovative Microparticles That Unlock New Insights Into Protein Degradation and Immune Cell Behavior
Florida State University

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells that uses engineered microparticles to track and analyze degradation processes more effectively than traditional methods. The work, which was published in ACS Applied Materials & Interfaces, has important implications for treating diseases such as cancer, Alzheimer’s disease and autoimmune disorders.

Released: 27-Mar-2025 6:10 PM EDT
MD Anderson Research Highlights for March 27, 2025
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: Biobreeding Technology Enables Rapid Development of Golden Grass Carp Germplasm
Released: 27-Mar-2025 5:20 PM EDT
Biobreeding Technology Enables Rapid Development of Golden Grass Carp Germplasm
Chinese Academy of Sciences

This study achieved CRISPR/Cas9-mediated genome editing in grass carp (Ctenopharyngodon idella), China's most economically vital freshwater fish. Targeting the tyrb gene critical for pigmentation were performed. Mutations confirmed by sequencing caused a golden phenotype with melanophore reduction. Using multiple gRNAs enhanced mutation rates (88.9%) and triggered large DNA deletions.

Released: 27-Mar-2025 10:20 AM EDT
Engenheiros de manufatura da Mayo Clinic estão prestes a entregar novas bioterapias
Mayo Clinic

Engenheiros de manufatura estão na vanguarda de trazer novos medicamentos derivados de fontes humanas, como células, sangue e genes, para os pacientes. Eles produzem o que muitas vezes são bioterapias pioneiras do seu tipo para doenças que anteriormente tinham poucas ou nenhuma opção de tratamento.

   
Released: 27-Mar-2025 9:45 AM EDT
Mayo Clinic Manufacturing Engineers on the Cusp of Delivering New Biotherapies
Mayo Clinic

Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients. They produce what are often first-of-their kind biotherapies for diseases that previously had few or no treatment options.

   
Released: 27-Mar-2025 9:15 AM EDT
Ingenieros de manufactura de Mayo Clinic están a punto de entregar nuevas bioterapias
Mayo Clinic

JACKSONVILLE, Florida — Ingenieros de manufactura están a la vanguardia de llevar nuevos medicamentos derivados de fuentes humanas, como células, sangre y genes, a los pacientes. Ellos producen lo que a menudo son bioterapias pioneras de su tipo para enfermedades que anteriormente tenían pocas o ninguna opción de tratamiento.

   
Released: 27-Mar-2025 9:05 AM EDT
Researchers Identifying Causes of Rare Neurological Conditions in Children Receive £1.1M in Funding
University of Portsmouth

Scientists have been given a £1.1m grant by the UKRI Medical Research Council (MRC) to continue their life-changing research, after identifying a new disease which causes some children’s brains to develop abnormally.

Released: 27-Mar-2025 8:10 AM EDT
CDI Labs Launches Technology Access Program for Custom PhIP-Seq Libraries for Massively Multiplexed Analysis of Serum Antibodies
CDI LABORATORIES, INC.

CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services. These services utilize phage display immunoprecipitation sequencing (PhIP-Seq), a powerful method of multiplexed analysis that combines next-generation proteomics with high-throughput DNA sequencing, to provide researchers with unparalleled insights into the intricate connection between antibodies and diseases.

Newswise: DNA Microscope Creates 3D Images of Organisms From the Inside Out
Released: 27-Mar-2025 6:00 AM EDT
DNA Microscope Creates 3D Images of Organisms From the Inside Out
University of Chicago Biological Sciences Division

UChicago researchers develop a new technology to create a spatial map of gene expression for an entire organism.

Released: 27-Mar-2025 12:05 AM EDT
مهندسو التصنيع في مايو كلينك على أعتاب تقديم علاجات حيوية جديدة
Mayo Clinic

جاكسونفيل، ولاية فلوريدا — يحتل مهندسو التصنيع الصدارة في جلب الأدوية الجديدة المشتقة من مصادر بشرية، مثل الخلايا والدم والجينات، للمرضى. وينتجون علاجات حيوية غالبًا ما تكون الأولى من نوعها لأمراض لم يكن لها في السابق سوى خيارات علاجية محدودة أو لم يكن لها أي خيارات.

   
Newswise: This Biotechnology Major Marches to the Beat of the Scarlet Knights
Released: 26-Mar-2025 8:50 PM EDT
This Biotechnology Major Marches to the Beat of the Scarlet Knights
Rutgers University-New Brunswick

Mukhilan Saravanakumar found a way to mix two passions – music and science – into a harmonious college experience at Rutgers University-New Brunswick.  The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in biotechnology and a double minor in data science and music.

Newswise: 002.jpg?itok=KSTPgLNp
Released: 26-Mar-2025 8:10 PM EDT
Nebraska Undergrads Uncover Ancient Secrets of Human Immunity
University of Nebraska-Lincoln

Nebraska undergrads uncover ancient secrets of human immunity



close
2.84677